pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·2h ago·1 min read
save

Study shows low extractables in single-use components support ADC manufacturing

Oct 19, 2026·read at BioPharma Dive ↗Neutral

Cytiva conducted extractables testing on disposable chromatography column housings and flow kits used in antibody-drug conjugate production.

The tests used dimethylacetamide (DMA) and dimethyl sulfoxide (DMSO), solvents common in the cytotoxin conjugation step, and applied exaggerated conditions to challenge the materials.

Analytical results identified only trace amounts of organic compounds and elements, indicating that the single-use parts, such as ReadyToProcess columns and AKTA flow kits, introduce minimal leachables.

The findings support the continued use of these single-use systems in ADC processes, addressing concerns about plastic and elastomer leachables when organic solvents are employed.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “Extractables in single-use systems used in ADC manufacturing”

read at BioPharma Dive ↗
1,622 words · retrieved 49m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
drugs
Rimso2ZINC2magnesium
topics
Antibody-Drug Conjugate (ADC)23Monoclonal Antibody12Oncology

related stories

  • 3d agoGSK laying off 1.2K+ in BelgiumBioSpace
  • May 13FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive
  • May 11Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCTonclive
  • May 8Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive
  • May 5Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCConclive